Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Gail Carson from the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) is nominated chair of WHO Global Outbreak Alert & Response Network (GOARN)

Dr Gail Carson, new chair of GOARN

The Global Outbreak Alert & Response Network is a network of over 270 institutions and partners around the world who work together on outbreak preparedness and response. The Operational Support Team is hosted by WHO Geneva and there are regional focal points at the WHO regional offices. Gail one of the Directors at the clinical research network ISARIC, University of Oxford became Chair of GOARN last week.

Dr Gail Carson qualified from Edinburgh Medical School in 1994. After obtaining her MRCP she studied the Diploma in Tropical Medicine and Hygiene at Liverpool. She completed her specialty training in Manchester and took up a Consultants post with the Health Protection Agency at Porton Down. Additionally, she carried out clinical work at Royal Liverpool University Hospital.

During her infectious diseases training she had opportunities to work with the WHO on viral haemorrhagic fevers, SARS and H5N1. This interest in emerging pathogen outbreaks has continued and is the reason why she took up the post with the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) in 2012. ISARIC is a network of clinical research networks working with the other disciplines such as public health to prepare and roll out an integrated outbreak research response to help improve the knowledge base to inform patient care and policy.

This nomination follows on from being GOARN Deputy Chair for 4 years and Research lead prior to that. Most recently leading on the new strategy for GOARN in partnership with the steering committee, regional focal points and partners. 

Dr Gail Carson says:

After being involved with GOARN over the past 22 years it is an absolute honour to be elected chair.  The pandemic has created great uncertainty in the global health preparedness and response space. GOARN has a new strategy to add value and to help with the remodelling of that space. I look forward to working with the GOARN OST, partners and stakeholders in implementing the strategy over the next 2 years. GOARN will continue to work closely with the WHO and align where we can to serve and work alongside the people who need us most.

Similar stories

Registration is open for The Global Health Network Conference 2022

To tackle disease we need evidence to be generated through every type of health research study. This conference aims to bring together health research teams, organisations, health-workers, policy makers and practitioners to explore together how health research can be embedded into every healthcare setting. Join us at The Global Health Network Conference 2022 at the University of Cape Town, South Africa, 24 – 25 November 2022

The inside story of Recovery: how the world’s largest COVID-19 trial transformed treatment – and what it could do for other diseases

Two years ago, the Recovery trial transformed the care of COVID patients with its dexamethasone announcement. Within four hours, the steroid was included in NHS treatment recommendations. Almost overnight, treatment of COVID patients around the world changed completely. It has been estimated that dexamethasone may have saved a million lives in the first nine months following the announcement. Recovery is a groundbreaking scientific machine which, from the outset, moved at unprecedented speed. In the first 100 days alone, the trial produced three groundbreaking results that would completely reshape COVID care.

RECOVERY trial celebrates two-year anniversary of life-saving dexamethasone result

Two years ago, the RECOVERY trial gave the world its first breakthrough against coronavirus: the discovery that an inexpensive steroid pill, dexamethasone, reduced deaths by up to a third from COVID-1. Within hours, the result was breaking news across the world and hospitals were adopting the drug into the standard care given to all patients with COVID-19. In the nine months following the discovery, dexamethasone saved an estimated one million lives worldwide.

Congratulations to our new Associate Professors

Our heartfelt congratulations to Melissa Kapulu, Francis Ndungu and Emelda Okiro from KWTRP, and to Hoa Thi Ngo and Sophie Yacoub from OUCRU who have been awarded Associate Professorships

Congratulations to Professor Sir David Warrell, appointed Knight Commander of the Order of St Michael and St George!

David Warrell, MORU founding director, has been appointed by the Queen ‘Knight Commander of the Order of St Michael and St George for services to global Health Research and Clinical Practice’. Please join us in congratulating Sir David on receiving this richly deserved high honour!

Congratulations Professor Kathryn Maitland, awarded an OBE in the Queen’s Birthday Honours

Kathryn Maitland, Professor of Paediatric Tropical Infectious Diseases and based at the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya, was appointed Officer of the Order of the British Empire (OBE) in the Queen’s Birthday Honours